Literature DB >> 26632539

Hepatocellular carcinoma: Advances in diagnostic imaging.

Haoran Sun1, Tianqiang Song.   

Abstract

Thanks to the growing knowledge on biological behaviors of hepatocellular carcinomas (HCC), as well as continuous improvement in imaging techniques and experienced interpretation of imaging features of the nodules in cirrhotic liver, the detection and characterization of HCC has improved in the past decade. A number of practice guidelines for imaging diagnosis have been developed to reduce interpretation variability and standardize management of HCC, and they are constantly updated with advances in imaging techniques and evidence based data from clinical series. In this article, we strive to review the imaging techniques and the characteristic features of hepatocellular carcinoma associated with cirrhotic liver, with emphasis on the diagnostic value of advanced magnetic resonance imaging (MRI) techniques and utilization of hepatocyte-specific MRI contrast agents. We also briefly describe the concept of liver imaging reporting and data systems and discuss the consensus and controversy of major practice guidelines.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26632539     DOI: 10.5582/ddt.2015.01058

Source DB:  PubMed          Journal:  Drug Discov Ther        ISSN: 1881-7831


  9 in total

1.  Capsaicin enhances the antitumor activity of sorafenib in hepatocellular carcinoma cells and mouse xenograft tumors through increased ERK signaling.

Authors:  Su-Shan Zhang; Yu-Hao Ni; Chen-Ru Zhao; Zhen Qiao; Hong-Xia Yu; Lu-Yao Wang; Jin-Yan Sun; Chen Du; Jia-Hao Zhang; Li-Ying Dong; KeWei Wang; Jian-Jun Gao
Journal:  Acta Pharmacol Sin       Date:  2017-11-30       Impact factor: 6.150

2.  Heptamethine carbocyanine DZ-1 dye for near-infrared fluorescence imaging of hepatocellular carcinoma.

Authors:  Jiaze An; Ningning Zhao; Caiqin Zhang; Yong Zhao; Dengxu Tan; Ya Zhao; Bing Bai; Hai Zhang; Boyang Jason Wu; Changhong Shi
Journal:  Oncotarget       Date:  2017-05-24

3.  NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye.

Authors:  Caiqin Zhang; Yong Zhao; Ningning Zhao; Dengxu Tan; He Zhang; Xue Chen; Hai Zhang; Jiaze An; Changhong Shi; Mengbin Li
Journal:  Contrast Media Mol Imaging       Date:  2018-03-08       Impact factor: 3.161

Review 4.  CT-MRI LI-RADS v2017: A Comprehensive Guide for Beginners.

Authors:  Francesca Patella; Filippo Pesapane; Enrico Maria Fumarola; Ilaria Emili; Riccardo Spairani; Salvatore Alessio Angileri; Silvia Tresoldi; Giuseppe Franceschelli; Gianpaolo Carrafiello
Journal:  J Clin Transl Hepatol       Date:  2018-02-22

5.  Comparison of Sonazoid contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid MRI for the histological diagnosis of hepatocellular carcinoma.

Authors:  Feiqian Wang; Kazushi Numata; Masahiro Okada; Makoto Chuma; Hiromi Nihonmatsu; Satoshi Moriya; Akito Nozaki; Katsuaki Ogushi; Wen Luo; Litao Ruan; Masayuki Nakano; Masako Otani; Yoshiaki Inayama; Shin Maeda
Journal:  Quant Imaging Med Surg       Date:  2021-06

6.  Factors Associated With Delay of Diagnosis of Hepatocellular Carcinoma in Patients With Cirrhosis.

Authors:  Debra T Choi; Jessica A Davila; Shubhada Sansgiry; Eric David; Hardeep Singh; Hashem B El-Serag; Yvonne Hsiao-Fan Sada
Journal:  Clin Gastroenterol Hepatol       Date:  2020-07-18       Impact factor: 13.576

Review 7.  An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence.

Authors:  Yu-Long Cai; Pei-Pei Song; Wei Tang; Nan-Sheng Cheng
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

Review 8.  Updates on the Diagnosis and Management of Hepatocellular Carcinoma.

Authors:  Aimun Raees; Muhammad Kamran; Hasan Özkan; Wasim Jafri
Journal:  Euroasian J Hepatogastroenterol       Date:  2021 Jan-Jun

9.  miR-130-3p Promotes MTX-Induced Immune Killing of Hepatocellular Carcinoma Cells by Targeting EPHB4.

Authors:  Liangtian Shao; Qing Ye; Moyang Jia
Journal:  J Healthc Eng       Date:  2021-07-23       Impact factor: 2.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.